PRESS RELEASE MedMen to acquire PharmaCann in all-stock transaction valued at US$682 million, the largest acquisition transaction in U.S. cannabis history. The acquisition doubles the number of states where MedMen has licenses to 12. The combined addressable market in these 12 states accounts for over 50 percent of the total estimated 2030 U.S. addressable market […]
PharmaCann LLC
PharmaCann Grows into New Markets
PRESS RELEASE Ohio Latest Extension of National Cannabis Company Oak Park, Ill. – (June 6, 2018) – On Monday, the Ohio Board of Pharmacy announced that PharmaCann, one of the country’s largest, vertically-integrated medical cannabis providers, was awarded a dispensary license in the Cincinnati area. Following an extensive review, PharmaCann is one of 56 licensees […]
Medical marijuana expansion could be steppingstone to recreational legalization in New York
There are several issues that need to be resolved before adult marijuana use should be legalized, industry insiders said. Pioneers of New York’s medical marijuana program are expressing cautious excitement over the prospect of adult use legalization. “This industry is probably the fastest moving industry there is right now,” said Jeremy Unruh, director of public […]
Sprinting Out of the Gate With Little Slowing Down On the Horizon: PharmaCann LLC
After The Compassionate Use of Medical Cannabis Pilot Program Act went into effect in January of 2014 in Illinois, Teddy Scott, founder and CEO of PharmaCann, a Ph.D. in molecular biophysics and a registered patent attorney in the law firm Polsinelli, where he focused on intellectual property issues, began discreetly crafting a plan. He wanted to […]
